BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Neocentromeres
,
Doxycycline
,
rs3825942
,
ERBB2
,
Response to oxidative stress
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Gall bladder carcinoma
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for Gall bladder carcinoma
Explore Curated Studies Results
Literature
Most Relevant Literature
Cowden Syndrome With Gall Bladder Polyps and Incidental Gall Bladder Carcinoma.
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-1…
Port-Site Metastases in Incidentally Detected Carcinoma Gall Bladder: Role of 18F-FDG PET/CT and Pat…
Expression of Human epidermal growth factor receptor 2, Survivin, Enhancer of zeste homolog -2, Cycl…
Castleman's disease in carcinoma gall bladder.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Int…
Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer
Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gal…
Does Timing of Completion Radical Cholecystectomy Determine the Survival in Incidental Carcinoma Gal…
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinom…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ